olgazonova.ru Mrna Analyst Ratings


MRNA ANALYST RATINGS

Complete Moderna Inc. stock information by Barron's. View real-time MRNA stock price and news, along with industry-best analysis %. Analyst Ratings. Moderna Inc has a total of 0 Wall St Analyst ratings. There are 0 buy ratings, 0 ratings, and 0 sell ratings. Since most analysts have a sell consensus rating. Broker Rating. Moderna currently has an average brokerage recommendation (ABR) of on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on. The average analyst rating for Moderna stock from 14 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market. Analysts' Consensus ; Mean consensus. OUTPERFORM ; Number of Analysts. 24 ; Last Close Price. USD ; Average target price. USD ; Spread / Average Target. +.

Moderna Inc's average analyst rating is Buy. Stock Target Advisor's own stock analysis of Moderna Inc is Neutral, which is based on 6 positive signals and 6. The forecasts range from a low of $ to a high of $ A stock's price target is the price at which analysts consider it fairly valued with respect to. Average Recommendation, Overweight ; Average Target Price, ; Number Of Ratings, 26 ; FY Report Date, 12/ ; Last Quarter's Earnings, Is Moderna stock a Buy, Sell or Hold? Moderna stock has received a consensus rating of hold. The average rating score is and is based on 23 buy ratings. Moderna Inc has a total of 0 Wall St Analyst ratings. There are 0 buy ratings, 0 ratings, and 0 sell ratings. Since most analysts have a sell consensus rating. Analyst Ratings of MODERNA INC(NASDAQ:MRNA) stock. Analyst ratings, forecast, price target, upgrades and downgrades. %. Analyst Ratings. Average price target from 26 ratings: $ Average score: Sell. Under. Hold. Over. Buy. Full Ratings · StockGrader. Rating: 12 analyst ratings ; JP Morgan. Jessica Fye. 66% 1-year accuracy. 19 / 29 met price target. 14%upside. $ Neutral. Maintained. ; Deutsche Bank. Moderna, Inc.: Financial analyst guidance for Moderna, Inc. Stock | Nasdaq: MRNA | Nasdaq. MRNA is currently covered by 20 analysts with an average price target of $ This is a potential upside of $ (%) from yesterday's end of day. Get Wall Street analysts ratings for Moderna, Inc. (MRNA). Buy or Sell this stock? See what the analysts say.

Get Wall Street analysts ratings for Moderna, Inc. (MRNA). Buy or Sell this stock? See what the analysts say. Fair Value. Research Analysis. Earnings Per Share. Estimate. Analyst Recommendations. Strong Buy. Buy. Hold. Underperform. Sell. Analyst Price Targets. Moderna (MRNA) has a Smart Score of 3 based on an analysis of 8 unique data sets, including Analyst Recommendations, Crowd Wisdom, and Hedge Fund Activity. Seeking Alpha's authors provide a stock rating for Moderna, Inc. (MRNA). Ratings range from 'Very Bullish' to 'Very Bearish'. Moderna Inc has a consensus price target of $ based on the ratings of 25 analysts. The high is $ issued by Wolfe Research on November 9, We've gathered opinions of 26 analysts rating MRNA stock in the past 3 months. Most of them backed up the neutral trend, and after taking into account other. Based on 17 Wall Street analysts who have issued ratings for Moderna in the last 12 months, the stock has a consensus rating of "Hold." Out of the 17 analysts. Moderna Inc. analyst ratings, historical stock prices, earnings estimates & actuals. MRNA updated stock price target summary. Above the chart, you will find the Month High, Mean, and Low Target Prices from analysts who provided ratings. Historical Ratings. The table shows the mean.

MRNA Stock Overview ; 52 Week Low, US$ ; Beta, ; 11 Month Change, % ; 3 Month Change, % ; 1 Year Change, %. Analyst Price Targets ; with a high estimate of ; and a low estimate of ; Sign in to your SmartPortfolio to see more analyst recommendations. Free Moderna (MRNA) analysis tools, including analyst ratings and target price forecasts, help you make informed investment decisions. On average, 12 Wall Street analysts forecast MRNA's earnings for to be -$2,,,, with the lowest MRNA earnings forecast at -$3,,,, and the. Moderna Analyst Ratings. All Analysts Top Analysts. Total Analysts. Consensus Rating. Hold. Price Target. $ Upside. %.

MRNA Stock Price Prediction: Why MRNA Could Explode in September 2024 - Huge Bullish Growth Ahead!'

%. Analyst Ratings. Sell; Under; Hold; Over; Buy. Number of Ratings 26 Full Ratings. Recent News. MarketWatch. Dow Jones. Read full story · Moderna Inc. MRNA price estimates And ratings. What are the current estimates For MRNA? The current price of MRNA is USD — it has decreased by −% in the past 24 hours. Watch Moderna, Inc. stock price performance more closely on the chart.

Nft Mmorpg Game | Why Is Refinancing So Difficult

30 31 32 33 34

Copyright 2017-2024 Privice Policy Contacts SiteMap RSS